[1]倪 杰,徐 晶,蒋 涛.基于网络药理学方法探讨桃红四物汤防治股骨头坏死的潜在分子机制[J].医学信息,2022,35(03):1-7,12.[doi:10.3969/j.issn.1006-1959.2022.03.001]
 NI Jie,XU Jing,JIANG Tao.The Mechanism of Taohong Siwu Decoction in the Treatment of Osteonecrosisof the Femoral Head Based on Network Pharmacology[J].Medical Information,2022,35(03):1-7,12.[doi:10.3969/j.issn.1006-1959.2022.03.001]
点击复制

基于网络药理学方法探讨桃红四物汤防治股骨头坏死的潜在分子机制()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
1-7,12
栏目:
出版日期:
2022-02-01

文章信息/Info

Title:
The Mechanism of Taohong Siwu Decoction in the Treatment of Osteonecrosisof the Femoral Head Based on Network Pharmacology
文章编号:
1006-1959(2022)03-0001-08
作者:
倪 杰1徐 晶1蒋 涛2
1.南京中医药大学,江苏 南京 210023;2.南京中医药大学附属常州市中医医院,江苏 常州 213003
Author(s):
NI Jie1XU Jing1JIANG Tao2
1.Nanjing University of Chinese Medicine,Nanjing 210023,Jiangsu,China;2.Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine,Changzhou 213003,Jiangsu,China
关键词:
桃红四物汤股骨头坏死网络药理学靶点基因信号通路
Keywords:
Taohong Siwu decoctionOsteonecrosis of the femoral headNetwork pharmacologyTarget genesSignal pathway
分类号:
R683
DOI:
10.3969/j.issn.1006-1959.2022.03.001
文献标志码:
A
摘要:
目的 运用网络药理学的方法,探索桃红四物汤防治股骨头坏死的可能分子机制,为基础实验研究提供新方向。方法 通过TCMSP平台获取桃红四物汤的相关活性成分及作用靶点;从GeneCards以及OMIM数据库获取与股骨头坏死相关的靶点基因,两者的交集即为桃红四物汤-股骨头坏死疾病交集基因。采用STRING平台构建靶标基因蛋白互作网络(PPI);利用Cytoscape3.7.1软件构建桃红四物汤-靶标-疾病调控网络,筛选核心靶点基因;最后对交集靶点进行GO功能富集分析与KEGG通路富集分析,统计桃红四物汤-股骨头坏死共同靶标的可能作用机制及相关信号通路。结果 通过筛选得到桃红四物汤的69个有效成分和160个作用靶点,从GeneCards以及OMIM数据库筛选得到股骨头坏死相关靶点基因245个,取其交集得到桃红四物汤-股骨头坏死疾病交集基因39个。筛选后得到核心靶点基因21个,并推断其作用机制可能与糖尿病并发症的晚期糖基化终末产物-晚期糖基化终末产物受体信号通路、白介素-17信号通路、低氧诱导因子-1信号通路、松弛肽信号通路、磷脂酰肌醇3-激酶/蛋白激酶B信号通路等有关,且白介素-6基因、血管内皮生长因子A基因、表皮生长因子受体基因、基质金属蛋白酶基因可能起到关键性作用。结论 多通路、多靶点共同作用是桃红四物汤防治股骨头坏死的一大特点。
Abstract:
Objective To explore the possible molecular mechanism of Taohong Siwu decoction in preventing and treating femoral head necrosis by network pharmacology, and to provide a new direction for basic experimental research.Methods The related active ingredients and targets of Taohong Siwu decoction were obtained by TCMSP platform. The target genes related to femoral head necrosis were obtained from GeneCards and OMIM databases, and the intersection of the two was the intersection gene of Taohong Siwu decoction and femoral head necrosis disease. Target gene protein interaction network (PPI) was constructed by STRING platform. Cytoscape 3.7.1 software was used to construct Taohong Siwu decoction-target-disease regulatory network and screen the core target genes. Finally, GO function enrichment analysis and KEGG pathway enrichment analysis of intersection targets were carried out, and the possible mechanism and related signaling pathways of Taohong Siwu decoction-femoral head necrosis common target were counted.Results A total of 69 effective components and 160 action targets of Taohong Siwu decoction were obtained by screening, and 245 target genes related to femoral head necrosis were obtained from GeneCards and OMIM database, and 39 intersection genes of Taohong Siwu decoction and femoral head necrosis disease were obtained by intersection. Twenty-one core target genes were obtained after screening, and it was speculated that the mechanism of action might be related to the receptor signaling pathway of late glycosylation product-late glycosylation end product, interleukin 17 signaling pathway, hypoxia-inducible factor-1 signaling pathway, relaxation peptide signaling pathway, phosphatidylinositol 3-kinase/protein kinase B signaling pathway and diabetic complications, and interleukin-6 gene, vascular endothelial growth factor A gene, epidermal growth factor receptor gene, and matrix metalloproteinases gene might play a key role.Conclusion The combined action of multiple pathways and multiple targets is a major feature of Taohong Siwu decoction in the prevention and treatment of femoral head necrosis.

参考文献/References:

[1]中国医师协会骨科医师分会骨循环与骨坏死专业委员会,中华医学会骨科分会骨显微修复学组,国际骨循环学会中国区.中国成人股骨头坏死临床诊疗指南(2020)[J].中华骨科杂志,2020,40(20):1365-1376.[2]邓攀,王星,纪海,等.桃红四物汤加减对股骨头坏死临床疗效及部分机制探讨[J].世界中医药,2019,14(9):2339-2343.[3]赵会晓.桃红四物汤联合针灸治疗早期非创伤性股骨头坏死47例临床观察[J].中国民族民间医药,2020,29(14):99-101.[4]徐辉辉,李索咪,范梦强,等.富血小板血浆联合桃红四物汤对激素性股骨头坏死大鼠股骨头组织VEGF、CD31、ALP、β-catenin蛋白表达的影响[J].中华中医药杂志,2020,35(3):1501-1504.[5]龙强.桃红四物汤加减治疗气滞血瘀型早期股骨头坏死临床观察[D].乌鲁木齐:新疆医科大学,2019.[6]姚金龙,冯海波,孙绍裘.桃红四物汤治疗创伤性股骨头坏死临床疗效的观察[J].中国医药科学,2019,9(21):9-12,59.[7]韩学明,孙忠良,徐建华,等.老年人血清炎症因子与骨密度变化及骨吸收相关性研究[J].中国骨质疏松杂志,2020,26(2):221-226.[8]Gao YH,Dong N,Yang C,et al.Elevated synovial fluid IL-33 and IL-6 levels and cartilage degeneration in stage Ⅲ osteonecrosis of the femoral head[J].Technol Health Care,2020,28(2):203-212.[9]Yamaguchi R,Kamiya N,Adapala NS,et al.HIF-1-Dependent IL-6 Activation in Articular Chondrocytes Initiating Synovitis in Femoral Head Ischemic Osteonecrosis[J].J Bone Joint Surg Am,2016,98(13):1122-1131.[10]Ren Y,Deng Z,Gokani V,et al.Anti-Interleukin-6 Therapy Decreases Hip Synovitis and Bone Resorption and Increases Bone Formation Following Ischemic Osteonecrosis of the Femoral Head[J].J Bone Miner Res,2021,36(2):357-368.[11]Kuroyanagi G,Adapala NS,Yamaguchi R,et al.Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model[J].Bone,2018(116):221-231.[12]Melincovici CS,Bosca AB,Susman S,et al.Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.[13]Dailiana ZH,Stefanou N,Khaldi L,et al.Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines[J].World J Orthop,2018,9(9):120-129. [14]Luo Y,Li D,Xie X,et al.Porous, lithium-doped calcium polyphosphate composite scaffolds containing vascular endothelial growth factor (VEGF)-loaded gelatin microspheres for treating glucocorticoid-induced osteonecrosis of the femoral head[J].Biomed Mater,2019,14(3):035013.[15]Ma XW,Cui DP,Zhao DW.Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head[J].Int J Clin Exp Med,2015,8(9):15528-15534.[16]Marie PJ,Hott M,Perheentupa J.Effects of epidermal growth factor on bone formation and resorption in vivo[J].Am J Physiol,1990,258(2 Pt 1):E275-E281.[17]Xian CJ.Roles of epidermal growth factor family in the regulation of postnatal somatic growth[J].Endocr Rev,2007,28(3):284-296.[18]Yi T,Lee HL,Cha JH,et al.Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling[J].J Cell Physiol,2008,217(2):409-422.[19]Basal O,Atay T,Ciris IM,et al.Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH)[J].Bosn J Basic Med Sci,2018,18(4):352-360. [20]Wang J,Shi X,Yang H,et al.Association between alcohol-induced osteonecrosis of femoral head and risk variants of MMPS in Han population based on a case-control study[J].Oncotarget,2017,8(38):64490-64498.[21]Grassel S,Beckmann J,Rath B,et al.Expression profile of matrix metalloproteinase-2 and -9 and their endogenous tissue inhibitors in osteonecrotic femoral heads[J].Int J Mol Med,2010,26(1):127-133. [22]Du J,Liu W,Jin T,et al.A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head[J].Oncotarget,2016,7(42):68434-68441.[23]Chen K,Eddens T,Trevejo-Nunez G,et al.IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae[J].Cell Host Microbe,2016,20(5):596-605. [24]Amatya N,Garg AV,Gaffen SL.IL-17 Signaling: The Yin and the Yang[J].Trends Immunol,2017,38(5):310-322.[25]Kim HJ,Seo SJ,Kim JY,et al.IL-17 promotes osteoblast differentiation, bone regeneration, and remodeling in mice[J].Biochem Biophys Res Commun,2020,524(4):1044-1050.[26]Lee Y.The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases[J].BMB Rep,2013,46(10):479-483.[27]Huang H,Kim HJ,Chang EJ,et al.IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling[J].Cell Death Differ,2009,16(10):1332-1343.[28]Ahluwalia A,Tarnawski AS.Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing[J].Curr Med Chem,2012,19(1):90-97.[29]Wu J,Yao L,Wang B,et al.Tao-Hong-Si-Wu Decoction ameliorates steroid-induced avascular necrosis of the femoral head by regulating the HIF-1α pathway and cell apoptosis[J].Biosci Trends,2016,10(5):410-417.[30]Zou D,Han W,You S,et al.In vitro study of enhanced osteogenesis induced by HIF-1α-transduced bone marrow stem cells[J].Cell Prolif,2011,44(3):234-243.[31]Cheng MS,Yi X,Zhou Q.Overexpression of HIF-1alpha in Bone Marrow Mesenchymal Stem Cells Promote the Repair of Mandibular Condylar Osteochondral Defect in a Rabbit Model[J].J Oral Maxillofac Surg,2021,79(2):345.e1-345.e15.[32]Ferlin A,De Toni L,Sandri M,et al.Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside[J].Br J Pharmacol,2017,174(10):1015-1024.[33]Valkovic AL,Bathgate RA,Samuel CS,et al.Understanding relaxin signalling at the cellular level[J].Mol Cell Endocrinol,2019(487):24-33.[34]Ferlin A,Pepe A,Facciolli A,et al.Relaxin stimulates osteoclast differentiation and activation[J].Bone,2010,46(2):504-513.[35]Moon JS,Kim SH,Oh SH,et al.Relaxin augments BMP-2-induced osteoblast differentiation and bone formation[J].J Bone Miner Res,2014,29(7):1586-1596.[36]Samakova A,Gazova A,Sabova N,et al.The PI3k/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia[J].Physiol Res,2019,68(Suppl 2):S131-S138. [37]史东梅,董明,陆颖,等.PI3K/Akt信号通路与骨破坏:问题与机制[J].中国组织工程研究,2020,24(23):3716-3722.[38]Ma J,Zhu L,Zhou Z,et al.The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway[J].Cell Prolif,2021,54(1):e12955.[39]Zhai Y,Wang Q,Li Y,et al.The higher osteoprotective activity of psoralidin in vivo than coumestrol is attributed by its presence of an isopentenyl group and through activated PI3K/Akt axis[J].Biomed Pharmacother,2018(102):1015-1024.[40]Asadipooya K,Uy EM.Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone:Review of the Literature[J].J Endocr Soc,2019,3(10):1799-1818.[41]Ding KH,Wang ZZ,Hamrick MW,et al.Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss[J].Biochem Biophys Res Commun,2006,340(4):1091-1097.[42]Lee EJ,Kang MK,Kim YH,et al.Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts[J].Biomolecules,2020,10(7):1052.

相似文献/References:

[1]黄幼玲.中药配合鹿瓜多肽治疗股骨头坏死临床效果观察[J].医学信息,2018,31(06):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
 HUANG You-ling.Clinical Observation on Treatment of Femoral Head Necrosis with Chinese Medicine Combined with Lugua Polypeptide[J].Medical Information,2018,31(03):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
[2]潘风雨,张涌泉.青壮年人群早期股骨头坏死治疗策略的选择[J].医学信息,2018,31(08):10.[doi:10.3969/j.issn.1006-1959.2018.08.003]
 PAN Feng-yu,ZHANG Yong-quan.Selection of Treatment Strategy for Early Femoral Head Necrosis in Young and Middle-aged Population[J].Medical Information,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.08.003]
[3]刘 锌,杜 斌,孙光权,等.血清岩藻糖苷酶在股骨头坏死保髋患者预后判断中的临床价值[J].医学信息,2018,31(19):64.[doi:10.3969/j.issn.1006-1959.2018.19.021]
 LIU Xin,DU Bin,SUN Guang-quan,et al.Clinical Value of Serum Fucosidase in Predicting the Prognosis of Hip Preservation patients with Osteonecrosis of Femoral Head[J].Medical Information,2018,31(03):64.[doi:10.3969/j.issn.1006-1959.2018.19.021]
[4]巫 娟,张 峰,郭 莉.VEGF与b-FGF在不同病因缺血性坏死股骨头中的表达及意义[J].医学信息,2018,31(20):78.[doi:10.3969/j.issn.1006-1959.2018.20.022]
 WU Juan,ZHANG Feng,GUO Li.Expression and Significance of VEGF and b-FGF in Avascular Necrosis of Femoral Head with Different Etiology[J].Medical Information,2018,31(03):78.[doi:10.3969/j.issn.1006-1959.2018.20.022]
[5]仲鹤鹤,杨 晋,刘 毅.关节镜辅助下髓芯减压联合钽棒置入治疗早期股骨头坏死的研究[J].医学信息,2018,31(20):186.[doi:10.3969/j.issn.1006-1959.2018.20.059]
 ZHONG He-he,YANG Jin,LIU Yi.Treatment of Early Femoral Head Necrosis by Arthroscopic Core Decompression Combined with Tantalum Rod Implantation[J].Medical Information,2018,31(03):186.[doi:10.3969/j.issn.1006-1959.2018.20.059]
[6]韩秀莲.CT与MRI诊断股骨头坏死的价值研究[J].医学信息,2018,31(21):176.[doi:10.3969/j.issn.1006-1959.2018.21.052]
 HAN Xiu-lian.Diagnostic Value of CT and MRI in the Diagnosis of Femoral Head Necrosis[J].Medical Information,2018,31(03):176.[doi:10.3969/j.issn.1006-1959.2018.21.052]
[7]王添兴,李国庆,汪 洋,等.空心加压螺钉与动力髋螺钉治疗股骨颈骨折术后股骨头坏死相关并发症的Meta分析[J].医学信息,2019,32(02):83.[doi:10.3969/j.issn.1006-1959.2019.02.024]
 WANG Tian-xing,LI Guo-qing,WANG Yang,et al.Meta-analysis of Complications Associated with Hollow Compression Screws and Dynamic Hip Screws in the Treatment of Femoral Head Necrosis after Femoral Neck Fracture[J].Medical Information,2019,32(03):83.[doi:10.3969/j.issn.1006-1959.2019.02.024]
[8]陈恒安,胡 海,刘金龙,等.股骨头坏死骨髓IL-6表达与骨髓水肿分级的相关性研究[J].医学信息,2019,32(03):65.[doi:10.3969/j.issn.1006-1959.2019.03.021]
 CHEN Heng-an,HU Hai,LIU Jin-long,et al.Correlation between Bone Marrow IL-6 Expression and Grade of Bone Marrow Edema in Osteonecrosis of Femoral Head[J].Medical Information,2019,32(03):65.[doi:10.3969/j.issn.1006-1959.2019.03.021]
[9]吴 严,李海波,苟永胜.股骨颈骨折后股骨头坏死的相关因素分析[J].医学信息,2019,32(07):115.[doi:10.3969/j.issn.1006-1959.2019.07.034]
 WU Yan,LI Hai-bo,GOU Yong-sheng.Analysis of Related Factors of Femoral Head Necrosis After Femoral Neck Fracture[J].Medical Information,2019,32(03):115.[doi:10.3969/j.issn.1006-1959.2019.07.034]
[10]谢卫强,巩 栋,高明暄,等.关节病性银屑病伴髋关节结核1例[J].医学信息,2019,32(07):189.[doi:10.3969/j.issn.1006-1959.2019.07.062]

更新日期/Last Update: 1900-01-01